Brii Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Brii Biosciences's estimated annual revenue is currently $20.8M per year.
- Brii Biosciences's estimated revenue per employee is $155,000
- Brii Biosciences's total funding is $415M.
- Brii Biosciences's current valuation is $1.4B.
Employee Data
- Brii Biosciences has 134 Employees.
- Brii Biosciences grew their employee count by -4% last year.
Brii Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder and CEO | Reveal Email/Phone |
2 | Executive Director, Chief Financial and Strategy Officer | Reveal Email/Phone |
3 | SVP, Head Patient Advocacy & Policy | Reveal Email/Phone |
4 | VP, Head IT and Data Sciences | Reveal Email/Phone |
5 | Head Discovery | Reveal Email/Phone |
6 | Head China R&D | Reveal Email/Phone |
7 | Head CNS Diseases Therapy Area | Reveal Email/Phone |
8 | VP Clinical Operations and Sciences | Reveal Email/Phone |
9 | VP Pharmaceutical Sciences | Reveal Email/Phone |
10 | Senior Director - Product Development at Brii Biosciences | Reveal Email/Phone |
Brii Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11.2M | 72 | -13% | N/A | N/A |
#2 | $5099.8M | 32902 | -4% | N/A | N/A |
#3 | $1.7M | 11 | 0% | N/A | N/A |
#4 | $0.6M | 4 | -56% | N/A | N/A |
#5 | $0.9M | 11 | -39% | N/A | N/A |
#6 | $1.7M | 11 | 10% | N/A | N/A |
#7 | $0.6M | 4 | -33% | N/A | N/A |
#8 | $4.8M | 31 | -6% | N/A | N/A |
#9 | $6.4M | 41 | 3% | N/A | N/A |
#10 | $4.2M | 27 | -18% | N/A | N/A |
What Is Brii Biosciences?
Brii Biosciences (Brii Bio) is a company committed to serving patients? needs and improving public health in China. Founded in early 2018, the company focuses on accelerating innovation and optimizing access to the latest medicines for Chinese patients. Brii Bio helps global partners drive growth and improve return on investment through better understanding of Chinese healthcare systems and access to the world?s second largest pharmaceutical market. The company?s focus is treatments for chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses. The company is headquartered in the People?s Republic of China and the United States, with offices in Shanghai, Beijing, San Francisco, and Durham, North Carolina.
keywords:N/A
$415M
Total Funding
134
Number of Employees
$20.8M
Revenue (est)
-4%
Employee Growth %
$1.4B
Valuation
N/A
Accelerator
Brii Biosciences News
China has approved Pfizer Inc's Paxlovid and Brii Biosciences Ltd's antibody-based medicine for mild and moderate COVID patients with high...
Brii Bio Presents New Data on BRII-835 (VIR-2218) in Chinese Patients with Chronic Hepatitis B at APASL 2022. (PRNewsfoto/Brii Biosciences...
Brii Biosciences Limited ("Brii Bio", stock code: 2137.HK) is a biotechnology company based in China and the United States committed to...
BEIJING and DURHAM, N.C., Nov. 17, 2021 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, today announced it has r ...
DURHAM, N.C. and BEIJING, Sept. 27, 2021 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, today announced the app ...
Other Companies in Durham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $18.8M | 134 | 40% | N/A |
#2 | $20.8M | 134 | 9% | N/A |
#3 | $19.7M | 136 | 6% | N/A |
#4 | $3.5M | 136 | -9% | N/A |
#5 | $28.1M | 137 | 10% | N/A |